Cargando…
Disputes over the production and dissemination of misinformation in the time of COVID-19
Ultimate coronavirus disease 2019 (COVID-19) mitigation and crisis resolution is dependent on trustworthy data and actionable information. At present time, there is still no cure for COVID-19, although some treatments are being used in severe illness. Regrettably, as the SARS‐CoV‐2 virus spreads, th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006495/ https://www.ncbi.nlm.nih.gov/pubmed/33930690 http://dx.doi.org/10.1016/j.rmed.2021.106380 |
_version_ | 1783672322775842816 |
---|---|
author | Cazzola, Mario de Novellis, Vito Bianco, Andrea Rogliani, Paola Matera, Maria Gabriella |
author_facet | Cazzola, Mario de Novellis, Vito Bianco, Andrea Rogliani, Paola Matera, Maria Gabriella |
author_sort | Cazzola, Mario |
collection | PubMed |
description | Ultimate coronavirus disease 2019 (COVID-19) mitigation and crisis resolution is dependent on trustworthy data and actionable information. At present time, there is still no cure for COVID-19, although some treatments are being used in severe illness. Regrettably, as the SARS‐CoV‐2 virus spreads, the lack of cure has been accompanied by an increasing amount of medical misinformation. In particular, there is a lot of misinformation about how to treat patients who have tested positive for SARS‐CoV‐2 and who are asymptomatic or have mild symptoms and for whom management at home is deemed appropriate. In this editorial, we highlight the risks deriving from this misinformation, which often arises from the publication of studies that are not conceptually and methodologically accurate. |
format | Online Article Text |
id | pubmed-8006495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80064952021-03-29 Disputes over the production and dissemination of misinformation in the time of COVID-19 Cazzola, Mario de Novellis, Vito Bianco, Andrea Rogliani, Paola Matera, Maria Gabriella Respir Med Editorial Ultimate coronavirus disease 2019 (COVID-19) mitigation and crisis resolution is dependent on trustworthy data and actionable information. At present time, there is still no cure for COVID-19, although some treatments are being used in severe illness. Regrettably, as the SARS‐CoV‐2 virus spreads, the lack of cure has been accompanied by an increasing amount of medical misinformation. In particular, there is a lot of misinformation about how to treat patients who have tested positive for SARS‐CoV‐2 and who are asymptomatic or have mild symptoms and for whom management at home is deemed appropriate. In this editorial, we highlight the risks deriving from this misinformation, which often arises from the publication of studies that are not conceptually and methodologically accurate. Elsevier Ltd. 2021-06 2021-03-29 /pmc/articles/PMC8006495/ /pubmed/33930690 http://dx.doi.org/10.1016/j.rmed.2021.106380 Text en © 2021 Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Cazzola, Mario de Novellis, Vito Bianco, Andrea Rogliani, Paola Matera, Maria Gabriella Disputes over the production and dissemination of misinformation in the time of COVID-19 |
title | Disputes over the production and dissemination of misinformation in the time of COVID-19 |
title_full | Disputes over the production and dissemination of misinformation in the time of COVID-19 |
title_fullStr | Disputes over the production and dissemination of misinformation in the time of COVID-19 |
title_full_unstemmed | Disputes over the production and dissemination of misinformation in the time of COVID-19 |
title_short | Disputes over the production and dissemination of misinformation in the time of COVID-19 |
title_sort | disputes over the production and dissemination of misinformation in the time of covid-19 |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006495/ https://www.ncbi.nlm.nih.gov/pubmed/33930690 http://dx.doi.org/10.1016/j.rmed.2021.106380 |
work_keys_str_mv | AT cazzolamario disputesovertheproductionanddisseminationofmisinformationinthetimeofcovid19 AT denovellisvito disputesovertheproductionanddisseminationofmisinformationinthetimeofcovid19 AT biancoandrea disputesovertheproductionanddisseminationofmisinformationinthetimeofcovid19 AT roglianipaola disputesovertheproductionanddisseminationofmisinformationinthetimeofcovid19 AT materamariagabriella disputesovertheproductionanddisseminationofmisinformationinthetimeofcovid19 |